Sturm, Ruger & Co. Files Definitive Proxy Statement Amidst Contentious Proxy Battle with Beretta
RGR sits 53% above its 52-week low of $28.33.
Summary
Sturm, Ruger & Co. has filed its definitive proxy statement, urging shareholders to reject activist investor Beretta Holding S.A.'s board nominees and approve an increase in authorized shares, intensifying a proxy contest over the company's future.
Key Events · Corporate Governance and Compliance · RGR
-
Definitive Proxy Filed for Contested Election
Sturm, Ruger & Co. filed its definitive proxy statement for the May 27, 2026 Annual Meeting, following preliminary filings from both the company and activist investor Beretta Holding S.A. The Board strongly opposes the four director nominees put forth by Beretta.
-
Authorized Shares Increase Proposed
Shareholders will vote on a proposal to increase authorized common stock from 40 million to 60 million shares. With 15,948,066 shares currently outstanding, if all 20 million new shares were issued, potential dilution would be 125.4%.
-
Board Rejected Beretta's Tender Offer
The Board previously rejected a partial tender offer from Beretta for up to 20.05% of outstanding shares at $44.80 per share, citing concerns about 'creeping acquisition of control' and disproportionate influence.
-
Antitrust Concerns Raised Against Beretta Nominees
The company highlighted potential Clayton Act and Sherman Act violations due to interlocking directorates if Beretta's nominees, particularly one serving on a Beretta subsidiary board, were elected.
Analysis · RGR · Manufacturing
This definitive proxy statement highlights a critical corporate governance battle at Sturm, Ruger & Co. The company is actively defending against a proxy contest initiated by Beretta Holding S.A., a competitor and 9.95% shareholder, which has nominated four directors. The Board's strong opposition to Beretta's nominees, coupled with its rejection of Beretta's partial tender offer at a premium, signals a deep disagreement over the company's strategic direction and control. The proposal to significantly increase authorized shares, if approved, could lead to substantial future dilution, providing the company with flexibility for capital raises or M&A but also creating an overhang for existing shareholders. Investors should closely monitor the outcome of the annual meeting on May 27, 2026, as it will determine the composition of the board and potentially influence the company's long-term strategy and independence.
At the time of this filing, RGR was trading at $43.21 on NYSE in the Manufacturing sector, with a market capitalization of approximately $677.3M. The 52-week trading range was $28.33 to $48.21. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.